Evidence map›Paper›PMID 41552135›Full record

ArticleCureus2025

When Immunosuppression Fails: Cardiac Myxoma Mimicking Systemic Lupus Erythematosus Flare With a Diagnostic Delay.

Gurdarshan Singh, Jaspreet Kaur

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Gurdarshan SinghCardiology, Patiala Heart Institute and Multispeciality Hospital, Patiala, IND.
Jaspreet KaurPathology and Laboratory Medicine, Civil Hospital Samana, Patiala, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 36-year-old woman with well-controlled systemic lupus erythematosus (SLE) and prior pulmonary tuberculosis (TB) developed fever, weight loss, anemia (hemoglobin 7.6 g/dL), thrombocytopenia (78,000/mm³), and elevated inflammatory markers (ESR 89 mm/hr, CRP 67 mg/L), with symptom onset five months earlier (Month 0). Complement levels were normal, anti-dsDNA was negative, ANA remained unchanged, and she had no new rash, serositis, or renal involvement. Notably, she had no cardiac symptoms or abnormal findings on examination at that time. During the first month (Month 1), she was presumptively diagnosed with a clinically active but serologically quiescent SLE flare, based on fever, cytopenias, and elevated inflammatory markers in the context of her established SLE, despite normal complement levels and negative anti-dsDNA. Over the next three months (Months 1-3), infections with common bacterial, viral, and fungal pathogens were systematically excluded and typical causes of cytopenias were evaluated. During this period, she received escalating immunosuppression with corticosteroids, mycophenolate, and cyclophosphamide. Initial mild symptom relief was observed but waned within 2-3 weeks, and after three months, both symptoms and objective markers showed minimal improvement: ESR and CRP remained elevated, while hemoglobin and platelet counts remained essentially unchanged. At month four (Month 4), persistent fever despite immunosuppression raised concern for TB reactivation; empirical four-drug antitubercular therapy was briefly initiated but complicated by hepatotoxicity requiring cessation. TB cultures returned negative. At month five (Month 5), syncope prompted echocardiography, revealing a large (3.9×3.2 cm) pedunculated left atrial myxoma attached to the interatrial septum, prolapsing through the mitral valve during diastole. Cardiac MRI confirmed the diagnosis. Interleukin-6 was markedly elevated (107 pg/mL, normal <7). Following surgical excision, complete symptom resolution occurred with normalization of cytopenias by three months, a progressive decline in inflammatory markers, and IL-6 reduction to 12 pg/mL by six months. Immunosuppression was de-escalated to hydroxychloroquine alone with no recurrence at 14-month follow-up. This case illustrates diagnostic delay resulting from cognitive biases, including anchoring on her established SLE diagnosis and confirmation bias from partial steroid response, while highlighting underappreciated clinical red flags. Echocardiography was probably not performed during the course of the disease, given the absence of cardiac symptoms or abnormal findings on examination, and because the systemic symptoms were attributed to inflammatory causes. Critical underappreciated features included seronegative inflammation with normal complements and inadequate response to immunosuppression-atypical for genuine lupus flares. Inadequate treatment response within 4-6 weeks should trigger diagnostic reassessment before escalation. Syncope or orthostatic symptoms in systemic illness mandate urgent echocardiography. Cardiac myxomas produce IL-6 in the majority of patients (frequency >75%), and systemic constitutional signs are observed in a substantial proportion, though not uniformly. This can produce IL-6-mediated inflammation indistinguishable from autoimmune flares.

Indexed as

anchoring biascardiac myxomadiagnostic errorinterleukin-6syncopesystemic lupus erythematosus

Identifiers

PMID41552135
PMCPMC12806559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.